Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s Locations section was updated to add Maryland and Victoria as locations and reorganize the location blocks. The HHS Vulnerability Disclosure link was removed and the revision label updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-24T15:35:18.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.2.0 to v3.3.2. This update does not appear to alter study details or other user-facing content.
    Difference
    0.1%
    Check dated 2025-11-25T14:33:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Deletion of the general government funding status notice that warned about potential updates and directed users to cc.nih.gov and opm.gov for operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:27:27.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The update appears to be cosmetic UI/layout changes with no changes to the study's core details such as title, conditions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:32:34.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T07:49:29.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:50:49.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.